Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03112265 · ClinicalTrials.gov registry record · NA

Using Neuroimaging to Understand Children's Mental Health and Treatment Outcomes

A NA study of Depression and Anxiety, sponsored by Harvard University.

Completed
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT03112265 is a NA study of Depression and Anxiety that has completed, run by Harvard University. The registered enrollment target is 100 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03112265, a NA study of Depression and Anxiety, has completed, sponsored by Harvard University.

COMPLETED
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The study will compare the impact of Child STEPs versus usual school-based therapy on neural and companion behavioral measures of self-regulation.

Interventions

  • BEHAVIORAL Treatment as usual
  • BEHAVIORAL Modular Approach to Therapy for Children with Anxiety, Depression, Trauma, and Conduct Problems
  • OTHER Monitoring and Feedback System

Study Locations (1)

Massachusetts

  • Harvard University - Cambridge

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2015-01
Est. Completion 2020-07-31
Phase NA

Sponsor

Harvard University

37 total trials

What the Registry Record Tells You About NCT03112265

The ClinicalTrials.gov registry entry for NCT03112265 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (87% lower). The listed sponsor is Harvard University, which has 37 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Depression appearing as the primary indexed condition, and to 3 interventions - of which Treatment as usual is the first listed.

NCT03112265 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT03112265 about?

NCT03112265 is a clinical study titled "Using Neuroimaging to Understand Children's Mental Health and Treatment Outcomes". The study will compare the impact of Child STEPs versus usual school-based therapy on neural and companion behavioral measures of self-regulation.

What is the current status of trial NCT03112265?

This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2015-01. Estimated completion is 2020-07-31.

What conditions does trial NCT03112265 study?

This clinical trial studies the following conditions: Depression, Anxiety, Trauma, Behavior Problems.

What interventions are being tested in trial NCT03112265?

The interventions under investigation include: Treatment as usual (BEHAVIORAL), Modular Approach to Therapy for Children with Anxiety, Depression, Trauma, and Conduct Problems (BEHAVIORAL), Monitoring and Feedback System (OTHER).

Who is sponsoring clinical trial NCT03112265?

This trial is sponsored by Harvard University, which has 37 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03112265 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.